99mtc-rbitistatin

Small moleculeexperimentalImaging agent

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Dec 1, 2008 (NCT00808626)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetRadiopharmaceutical

    radiopharmaceutical

Chemistry & pharmacology

Imaging
99-technetium

Oral

No

Parenteral

No

Topical

No

Also known as

  • 99mtc-rbitistatin
  • bitistatin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00808626Phase 1/Phase 2 (Phase 2)Dec 1, 2008Temple University
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Temple UniversityAcademic/Hospital1112008
1 organizations
Page 1 / 1